Global Advanced Parenteral Drug Delivery Market By Product Type (Prefillable Syringes, Injectors Cartridges, Hypodermic Syringes, and IV Catheters Parenteral Delivery Devices), By Application (Central Nervous System Agents, Respiratory Agents, Hormones & Related Agents, Gastrointestinal Agents, Cardiovascular Agents, Anti-Infective Agents, Nutritional Agents, and Genito-Urinary Agents), By End-User (Government Hospitals, Private Hospitals and Clinics, and Healthcare Organizations) Global Advanced Parenteral Drug DeliveryIndustry Analysis, Size, Share, Growth, Trends, and Forecasts 2019-2025

Check Today's Best Price

$3500 Buy Now
Global Advanced Parenteral Drug Delivery market is estimated to reach $XX Million by 2025; growing at a CAGR of XX% till 2025.
  • Global Advanced Parenteral Drug Delivery Market: Overview

    Global Advanced Parenteral Drug Delivery market is estimated to reach $XX Million by 2025; growing at a CAGR of XX% till 2025.

    Parenteral drug delivery methods are the deliveries that are given other than the oral route. Several technological advances have been made in the area of parenteral drug delivery, leading to the development of superior systems that permit drug targeting and the sustained or controlled release of parenteral medicines. Parenteral formulations, mainly intravascular ones, offer a unique prospect for direct access to the bloodstream and rapid onset of drug action and target to specific organ and tissue sites.

    Global Advanced Parenteral Drug Delivery Market: Growth Factors

    Direct access of the drug into the bloodstream and rapid onset of drug action at specific target sites, increasing adoption of novel biological products and biosimilar, and increasing prevalence of chronic disorders such as diabetes, cardiovascular diseases, and cancer are key driving factors of the market. However, difficult to reverse the drug’s physiological effect and the high cost associated with the manufacturing and packaging requirements of parental dosage form might hamper the market growth. Moreover, technological advancement in the area of parenteral drug delivery systems and increasing demand for minimally invasive surgeries would provide lucrative opportunities for the market in the coming years.

    Global Advanced Parenteral Drug Delivery Market: Segmentation

    The global advanced parenteral drug delivery market is mainly classified based on Product type, application, and end-user. Product type is further segmented into prefillable syringes, injectors cartridges, hypodermic syringes, and IV catheters parenteral delivery devices. Based on application, the market is divided into central nervous system agents, respiratory agents, hormones & related agents, gastrointestinal agents, cardiovascular agents, anti-infective agents, nutritional agents, genito-urinary agents. By end-user, the market is further divided into government hospitals, private hospitals and clinics, and healthcare organizations.

    Global Advanced Parenteral Drug Delivery Market: Regional Analysis

    Based on geography, the global advanced parenteral drug delivery market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

    Global Advanced Parenteral Drug Delivery Market: Competitive Players

    Key players operating in the market include Abbott Laboratories, Amgen, AptarGroup, AstraZeneca, Baxter, Becton, Boston Scientific, Bristol-Myers Squibb, Dickinson, GlaxoSmithKline, Hoffmann-La Roche, Novartis, and Pfizer among others.

    Advanced Parenteral Drug Delivery Market Key Segments:

    By Product Type

    • Prefillable Syringes
    • Injectors Cartridges
    • Hypodermic Syringes
    • IV Catheters Parenteral Delivery Devices

    By Application

    • Central Nervous System Agents
    • Respiratory Agents
    • Hormones & Related Agents
    • Gastrointestinal Agents
    • Cardiovascular Agents
    • Anti-Infective Agents
    • Nutritional Agents
    • Genito-Urinary Agents

    By End-User

    • Government Hospitals
    • Private Hospitals and Clinics
    • Healthcare Organizations

    By Geography

    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • U.K
      • Germany
      • France
      • Italy
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • South Korea
      • Rest of Asia Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • Middle East & Africa
      • GCC Countries
      • Egypt
      • South Africa
      • Rest of Middle East & Africa
    keyboard_arrow_up
  • Table of Content

    1. Market Introduction
    1.1. Executive Summary
    1.2. Market Definition
    1.3. Market Scope

    2. Research Methodology
    2.1. Primary Research
    2.2. Research Methodology
    2.3. Assumptions & Exclusions
    2.4. Secondary data sources

    3. Advanced Parenteral Drug Delivery Market Overview
    3.1. Report Segmentation & Scope
    3.2. Key Market Trend
    3.3. Drivers
    3.3.1. Direct access of the drug into the bloodstream and rapid onset of drug action at specific target sites
    3.3.2. Increasing adoption of novel biological products and biosimilar
    3.3.3. Increasing prevalence of chronic disorders such as diabetes, cardiovascular diseases and cancer
    3.4. Restraints
    3.4.1. Difficult to reverse its physiological effect
    3.4.2. High cost associated with the manufacturing and packaging requirements of parental dosage form
    3.5. Opportunity
    3.5.1. Technological advancement in the area of parenteral drug delivery systems
    3.5.2. Increasing demand for minimally invasive surgeries
    3.6. Porter’s Five Forces Analysis
    3.6.1. Porter’s Five Forces Analysis
    3.7. Market Share Analysis

    4. Product Type Overview
    4.1. Introduction
    4.1.1. Market Size & Forecast
    4.2. Prefillable Syringes
    4.2.1. Market Size & Forecast
    4.3. Injectors Cartridges
    4.3.1. Market Size & Forecast
    4.4. Hypodermic Syringes
    4.4.1. Market Size & Forecast
    4.5. IV Catheters Parenteral Delivery Devices
    4.5.1. Market Size & Forecast

    5. Application Overview
    5.1. Introduction
    5.1.1. Market Size & Forecast
    5.2. Central Nervous System Agents
    5.2.1. Market Size & Forecast
    5.3. Respiratory Agents
    5.3.1. Market Size & Forecast
    5.4. Hormones & Related Agents
    5.4.1. Market Size & Forecast
    5.5. Gastrointestinal Agents
    5.5.1. Market Size & Forecast
    5.6. Cardiovascular Agents
    5.6.1. Market Size & Forecast
    5.7. Anti-Infective Agents
    5.7.1. Market Size & Forecast
    5.8. Nutritional Agents
    5.8.1. Market Size & Forecast
    5.9. Genito-Urinary Agents
    5.9.1. Market Size & Forecast

    6. End-User Overview
    6.1. Introduction
    6.1.1. Market Size & Forecast
    6.2. Government Hospitals
    6.2.1. Market Size & Forecast
    6.3. Private Hospitals and Clinics
    6.3.1. Market Size & Forecast
    6.4. Healthcare Organizations
    6.4.1. Market Size & Forecast

    7. Advanced Parenteral Drug Delivery Market Regional Overview
    7.1. Introduction
    7.1.1. Market Size & Forecast
    7.2. North America Advanced Parenteral Drug Delivery Market
    7.2.1. North America Market Size & Forecast, By Country
    7.2.2. North America Market Size & Forecast, By Product Type
    7.2.3. North America Market Size & Forecast, By Application
    7.2.4. North America Market Size & Forecast, By End-User
    7.2.5. The U.S.
    7.2.5.1. Market Size and Forecast
    7.2.6. Canada
    7.2.6.1. Market Size and Forecast
    7.2.7. Mexico
    7.2.7.1. Market Size and Forecast
    7.3. Europe Advanced Parenteral Drug Delivery Market
    7.3.1. Europe Market Size & Forecast, By Country
    7.3.2. Europe Market Size & Forecast, By Product Type
    7.3.3. Europe Market Size & Forecast, By Application
    7.3.4. Europe Market Size & Forecast, By End-User
    7.3.5. Germany
    7.3.5.1. Market Size and Forecast
    7.3.6. France
    7.3.6.1. Market Size and Forecast
    7.3.7. UK
    7.3.7.1. Market Size and Forecast
    7.3.8. Italy
    7.3.8.1. Market Size and Forecast
    7.3.9. Spain
    7.3.9.1. Market Size and Forecast
    7.3.10. Rest of Europe
    7.3.10.1. Market Size and Forecast
    7.4. Asia-Pacific Advanced Parenteral Drug Delivery Market
    7.4.1. Asia-Pacific Market Size & Forecast, By Country
    7.4.2. Asia-Pacific Market Size & Forecast, By Product Type
    7.4.3. Asia-Pacific Market Size & Forecast, By Application
    7.4.4. Asia-Pacific Market Size & Forecast, By End-User
    7.4.5. Japan
    7.4.5.1. Market Size and Forecast
    7.4.6. China
    7.4.6.1. Market Size and Forecast
    7.4.7. Australia
    7.4.7.1. Market Size and Forecast
    7.4.8. India
    7.4.8.1. Market Size and Forecast
    7.4.9. South Korea
    7.4.9.1. Market Size and Forecast
    7.4.10. Rest of Asia-Pacific
    7.4.10.1. Market Size and Forecast
    7.5. South America Advanced Parenteral Drug Delivery Market
    7.5.1. South America Market Size & Forecast, By Country
    7.5.2. South America Market Size & Forecast, By Product Type
    7.5.3. South America Market Size & Forecast, By Application
    7.5.4. South America Market Size & Forecast, By End-User
    7.5.5. Brazil
    7.5.5.1. Market Size and Forecast
    7.5.6. Argentina
    7.5.6.1. Market Size and Forecast
    7.5.7. Rest of South America
    7.5.7.1. Market Size and Forecast
    7.6. Middle East & Africa Advanced Parenteral Drug Delivery Market
    7.6.1. Middle East & Africa Market Size & Forecast, By Country
    7.6.2. Middle East & Africa Market Size & Forecast, By Product Type
    7.6.3. Middle East & Africa Market Size & Forecast, By Application
    7.6.4. Middle East & Africa Market Size & Forecast, By End-User
    7.6.5. GCC Countries
    7.6.5.1. Market Size and Forecast
    7.6.6. Egypt
    7.6.6.1. Market Size and Forecast
    7.6.7. South Africa
    7.6.7.1. Market Size and Forecast
    7.6.8. Rest of Middle East & Africa
    7.6.8.1. Market Size and Forecast

    8. Company Profile
    8.1. Abbott Laboratories
    8.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    8.1.2. Abbott Laboratories Product Category, Application, and Specification
    8.1.3. Abbott Laboratories Financial Performance (2016-2018)
    8.1.4. Main Business/Business Overview
    8.2. Amgen
    8.3. AptarGroup
    8.4. AstraZeneca
    8.5. Baxter
    8.6. Becton
    8.7. Boston Scientific
    8.8. Bristol-Myers Squibb
    8.9. Dickinson
    8.10. GlaxoSmithKline
    8.11. Hoffmann-La Roche
    8.12. Novartis
    8.13. Pfizer

    keyboard_arrow_up
  • Key Market Players

    • Abbott Laboratories
    • Amgen
    • AptarGroup
    • AstraZeneca
    • Baxter
    • Becton
    • Boston Scientific
    • Bristol-Myers Squibb
    • Dickinson
    • GlaxoSmithKline
    • Hoffmann-La Roche
    • Novartis
    • Pfizer
    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market

CLIENTS